|
多波长激光联合曲安奈德球后注射治疗非增殖性糖尿病性视网膜病变黄斑水肿的临床观察
|
Abstract:
[1] | Yang, W., Lu, J., Weng, J., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1091. https://doi.org/10.1056/NEJMoa0908292 |
[2] | Klein, B.E. (2007) Overview of Epidemiologic Studies of Diabetic Retinopathy. Ophthalmic Epidemiology, 14, 179-183.
https://doi.org/10.1080/09286580701396720 |
[3] | 张大卫, 张蕊, 杨敏, 等. 球周注射曲安奈德联合全视网膜光凝治疗糖尿病黄斑水肿疗效观察[J]. 疑难病杂志, 2016, 15(12): 1263-1267. |
[4] | Alvi, R., Memon, M.S., Shera, S., et al. (2016) Visual Outcome of Laser Treatment in Diabetic Macular Edema: Study from an Urban Diabetes Care Center. Pakistan Journal of Medical Sciences, 32, 1229-1233.
https://doi.org/10.12669/pjms.325.10597 |
[5] | 徐静娴, 张贤亮, 石壮, 等. 糖尿病视网膜病变激光光凝术后黄斑区脉络膜厚度变化的观察[J]. 中国实用眼科杂志, 2015, 33(6): 598-602. |
[6] | 梁丽, 单明华, 徐斌, 等. 传统格栅样激光与577nm黄色微脉冲激光光凝治疗视网膜静脉阻塞并发黄斑水肿的疗效比[J]. 河北医科大学学报, 2015, 33(3): 356-358. |
[7] | Bressler, N.M., Beck, R.W., Ferris, F.L., et al. (2011) Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. The New England Journal of Medicine, 16, 2234-237. https://doi.org/10.1056/NEJMct0908432 |
[8] | 张磊, 刘大川, 吴航. 糖尿病视网膜病变患眼激光光凝治疗前后黄斑区脉络膜厚度的增强深部成像技术测量[J]. 中华眼底病杂志, 2014, 30(6): 562-565. |
[9] | 卢百阳, 武志峰, 孙松, 等. 全视网膜光凝对糖尿病视网膜病变神经纤维层及黄斑厚度的影响[J]. 山东医药, 2010, 50(32): 12-15. |
[10] | 董秀清, 冯松福, 柯晓云. 应用光学相干断层扫描量化评估糖尿病黄斑水肿的临床研究[J]. 眼科新进展, 2017, 37(2): 133-136. |
[11] | 刘祥杰. 糖尿病性视网膜病变激光治疗时机[J]. 临床医学, 2015(3): 95-96. |
[12] | Avery, R.L. and Gordon, G.M. (2016) Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis. JAMA Ophthalmology, 134, 21-29.
https://doi.org/10.1001/jamaophthalmol.2015.4070 |
[13] | 齐慧君, 黎晓新. 糖尿病性黄斑水肿的激光治疗[J]. 眼科, 2005, 14(4): 234-236. |
[14] | 刘新, 邹吉新, 张立军, 等. PASCAL激光一次性全视网膜光凝治疗增殖性糖尿病视网膜病变[J]. 国际眼科杂志, 2016, 16(4): 712-715. |
[15] | Hu, Y., Zhang, T., Wang, K., et al. (2015) Changes in Choroidal Thickness after Panretinal Photocoagulation in Patients with Type 2 Diabetes. Retina, 35, 695-703. https://doi.org/10.1097/IAE.0000000000000381 |
[16] | Nguyen, Q.D., Brown, D.M., Marcus, D.M., et al. (2012) Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE. Ophthalmology, 119, 789-801.
https://doi.org/10.1016/j.ophtha.2011.12.039 |
[17] | Massin, P., Audren, F., Haouchine, B., Erginay, A., Bergmann, J.F., Benosman, R., et al. (2004) Intravitreal Triamcinolone Acetonide for Diabetic Diffuse Macular Edema Preliminary Results of a Prospective Controlled Trial. Ophthalmology, 111, 218-224. https://doi.org/10.1016/j.ophtha.2003.05.037 |
[18] | Jonas, J.B., Kreisig, I. and Sotker, A. (2003) Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema. Archives of Ophthalmology, 121, 57-61. https://doi.org/10.1001/archopht.121.1.57 |
[19] | Bonini-Filho, M.A., Jorge, R., Barbosa, J.C., et al. (2005) Intravitreal Injection versus Sub-Tenon’s Infusion of Triamcinolone Ace-Tonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial. Investigative Ophthalmology & Visual Science, 46, 3845-38499. https://doi.org/10.1167/iovs.05-0297 |
[20] | 潘竹娟, 张志辉, 樊飞红, 等. 全视网膜光凝联合雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效及费用比较[J]. 国际眼科杂志, 2018, 18(4): 682-685. |
[21] | 翁宏武, 王柯鳗, 马海智, 等. 玻璃体内注射曲安奈德联合黄斑部格栅样光凝治疗弥漫性糖尿病性黄斑水肿[J]. 眼科新进展, 2016, 36(11): 1050-1053. |
[22] | 褚梦琪. 视网膜静脉阻塞继发黄斑水肿的最新治疗进展[J]. 中华实验眼科杂志, 2018, 36(1): 65. |
[23] | 谢碧华, 何宇, 辛梅, 等. 曲安奈德与雷珠单抗辅助治疗弥漫性糖尿病性黄斑水肿的疗效比较[J]. 国际眼科杂志, 2018, 18(6): 1089-1092. |
[24] | Pak, K.Y., Choi, B.S., Park, S.W., et al. (2017) Comparison of Vitrectomized with Nonvitrectomized Eyes after Subtenon Injection of Triamcinolone Acetonide to Treat Diabetic Macular Edema: Retrospective Comparative Analysis of an Interventional Case Series. Indian Journal of Ophthalmology, 65, 488-492. https://doi.org/10.4103/ijo.IJO_627_16 |